Dr. Martens plc (LON:DOCS) Insider Jon Mortimore Buys 100 Shares of Stock

Dr. Martens plc (LON:DOCS – Get Rating) insider Jon Mortimore acquired 100 shares of the company’s stock in a transaction that occurred on Monday, March 13th. The stock was bought at an average price of GBX 140 ($1.71) per share, with a total value of £140 ($170.63).

Jon Mortimore also recently made the following trade(s):

• On Wednesday, January 11th, Jon Mortimore acquired 72 shares of Dr. Martens stock. The stock was bought at an average price of GBX 208 ($2.54) per share, with a total value of £149.76 ($182.52).

Dr. Martens Stock Down 0.8 %

Shares of Dr. Martens stock opened at GBX 138.90 ($1.69) on Wednesday. Dr. Martens plc has a 1 year low of GBX 133.70 ($1.63) and a 1 year high of GBX 295.21 ($3.60). The business has a 50-day moving average of GBX 164.81 and a two-hundred day moving average of GBX 207.14. The company has a market capitalization of £1.39 billion, a P/E ratio of 818.24, a price-to-earnings-growth ratio of 0.05 and a beta of 0.03. The company has a debt-to-equity ratio of 125.74, a current ratio of 2.39 and a quick ratio of 1.13.

Dr. Martens Cuts Dividend

The company also recently disclosed a dividend, which was paid on Friday, February 3rd. Stockholders of record on Thursday, January 5th were given a dividend of GBX 1.56 ($0.02) per share. The ex-dividend date of this dividend was Thursday, January 5th. This represents a dividend yield of 0.54%. Dr. Martens’s dividend payout ratio is currently 3,529.41%.

Analyst Ratings Changes

Several equities research analysts have issued reports on the company. JPMorgan Chase & Co. restated an “outperform” rating and issued a GBX 350 ($4.27) price target on shares of Dr. Martens in a report on Friday, November 18th. Numis Securities restated an “add” rating and issued a GBX 180 ($2.19) price target on shares of Dr. Martens in a report on Friday, February 24th.

Dr. Martens Company Profile

(Get Rating)

Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Its product segments include originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name.